Your browser doesn't support javascript.
loading
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; Johansson, Ann-Sofie; Molin, Daniel; Tavelin, Björn; Näslund, Ulf; Melin, Beatrice.
Afiliação
  • Andersson A; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Enblad G; Department of Immunology, Genetics and Pathology, Section Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden.
  • Erlanson M; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Johansson AS; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Molin D; Department of Immunology, Genetics and Pathology, Section Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden.
  • Tavelin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Näslund U; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Melin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Ups J Med Sci ; 1262021.
Article em En | MEDLINE | ID: mdl-33889307

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Doenças Cardiovasculares Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Doenças Cardiovasculares Idioma: En Ano de publicação: 2021 Tipo de documento: Article